Who we are

The EOSC4Cancer consortium comprises 29 parties, as well as four affiliated entities,  from 13 countries.

The principal investigators in EOSC4Cancer are Prof. Alfonso Valencia and Dr. Salvador Capella-Gutierrez. Prof. Alfonso,  director of the Spanish National Bioinformatics Institute (INB-ISCIII), is dedicated to the application of machine learning and artificial intelligence to Personalized Medicine, and development of software platforms for the extraction, integration and representation of big data for large-scale genome projects. Dr. Capella-Gutierrez  leads the Spanish National Bioinformatics (INB) Coordination Node at the Barcelona Supercomputing Center (BSC) focussing on the development of long-term infrastructures to facilitate the scientific benchmarking and technical monitoring of bioinformatics tools, web services and workflows in the context of ELIXIR.